Skip to main content
. 2017 Apr 20;8(30):50034–50050. doi: 10.18632/oncotarget.17293

Table 1. Baseline characteristics of studies associated with the risk of RCC included in the meta-analysis.

Ref. Year Surname Ethnicity SOC Genotyping Cases Controls Gene polymorphism NOS HWE
[26] 2015 Yang Asian HB Taqman 191 376 −2578C/A, −1154G/A, −634G/C, +936C/T 6 Y
[23] 2015 Shen Asian HB PCR-RFLP 360 360 −2578C/A, +1612G/A, +936C/T, −634G/C 5 Y
[24] 2015 Xian Asian HB PCR-RFLP 266 532 −2578C/A, +1612G/A, +936C/T, −634G/C 5 Y
[25] 2015 Lu Asian HB PCR-RFLP 412 824 −2578C/A,+1612G/A,+460T/C, +936C/T, −634G/C 5 Y
[27] 2014 Qin Asian HB Taqman 859 1004 +405G/C 7 Y
[28] 2013 Sáenz-López Caucasian HB Taqman 216 280 −2578C/A, +460T/C, +405G/C, +936C/T 6 Y
[29] 2011 Ajaz Asian HB PCR-RFLP 143 106 −2578C/A,+936C/T 5 Y
[30] 2010 Bruyère Caucasian HB PCR-RFLP 51 202 +460T/C, +405G/C, +936C/T, −1154G/A 5 Y
[31] 2009 Ricketts Caucasian HB PCR-RFLP 317 295 −1154G/A 6 Y
[32] 2002 Abe Asian HB PCR-RFLP 145 145 +936C/T, +1612G/A 5 Y

SOC: source of control; HB: hospital-based; HWE: Hardy–Weinberg equilibrium.

NOS: Newcastle-Ottawa Scale